St. Louis-based Ascension has become the third-largest ASC operator after its $3.9 billion acquisition of AmSurg expanded its footprint to more than 300 surgery centers. But while the scale is similar to the dominant for-profit players in the ASC space, Ascension’s strategy is fundamentally different. Thomas Aloia, MD, executive vice president and chief clinical officer at Ascension, spoke with Becker’s about what the deal means from a clinical perspective, how the system plans to leverage AmSurg expertise to build a hub-and-spoke ambulatory network across nine markets and why he thinks “ASC” is the wrong term for what these centers are becoming.
Read the full article: What Separates Ascension’s ASC Playbook from For-Profit Competitors //
Source: https://www.beckershospitalreview.com/finance/what-separates-ascensions-asc-playbook-from-for-profit-competitors/